NCT07598461

Brief Summary

The goal of this clinical trial is to find out whether using a splintless surgical approach improves the accuracy of maxillomandibular advancement (MMA) surgery for treating obstructive sleep apnea (OSA) in adults. The study will also look at the safety, functional outcomes, and cost-effectiveness of the splintless approach. The main questions it aims to answer are: Does the splintless approach lead to more accurate surgical movements of the jaws compared to the conventional splint-based method? What are the safety profile, functional outcomes, and cost-effectiveness of the splintless approach? Researchers will compare splintless MMA to conventional MMA. Patients will: Undergo MMA surgery using either the splintless or splint-based method; Attend regular follow-up visits as part of routine care; Complete questionnaires and undergo assessments at various time points; Receive one additional CT scan (24 months after surgery) and one overnight sleep study (60 months after surgery). Bedpartners of patients will: Complete questionnaires at various time points. This trial will help determine whether the splintless approach is a better, safer, and more effective alternative for treating OSA with MMA surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
76mo left

Started Dec 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

4.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2033

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

1.6 years

First QC Date

May 6, 2026

Last Update Submit

May 13, 2026

Conditions

Keywords

OSAMaxilomandibular advancement surgeryMMAPatient-specific implantsSplintless orthognathic

Outcome Measures

Primary Outcomes (1)

  • Surgical accuracy

    Because the main objective of MMA for OSA is achieving the planned advancement and counter-clockwise rotation to relieve the upper airway collapse, anteroposterior translation of the maxilla and mandible, and pitch of the maxilla and mandible are the main study parameters. The postoperative CT scan is superimposed on the preoperative virtual planning. The absolute difference between the planned value for a parameter and the postoperative acquired value will be calculated, which provides an intuitive accuracy measurement of MMA surgery.

    1 week after MMA

Secondary Outcomes (28)

  • Other translational surgical movement parameters

    1 week after MMA

  • Other rotational surgical movement parameters

    1 week after MMA

  • Duration of surgery

    During MMA surgery

  • Blood loss

    During MMA surgery

  • Adverse events/complications

    During MMA surgery and follow-Ups (up to 60 months postoperatively)

  • +23 more secondary outcomes

Study Arms (2)

Splintless group

EXPERIMENTAL

In the splintless group, MMA using patient-specific osteotomy guides and fixation implants (i.e., splintless MMA) will be executed.

Procedure: Splintless MMA surgery

Splint group

ACTIVE COMPARATOR

In the splint group, conventioanl MMA using surgical splints (i.e., splint MMA) will be executed.

Procedure: Splint MMA surgery

Interventions

Splintless orthognathic surgery is a more recent technical innovation in Oral and Maxillofacial surgery, in which patient-specific computer-aided design and manufacturing (CAD/CAM) surgical cutting guides and fixation implants are used to improve surgical precision. Splintless MMA sugery involves virtual surgical planning, surgical procedures, and postoperative monitoring.

Splintless group

In splint MMA surgery, surgical procedure is virtually planned in three dimensions (3D) and the surgical planning is transfered to the operating room with 3D-printed intermediate and final splints. These splints are used during surgery to place and fixate the maxilla and mandible in the planned position.

Splint group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For OSA patients:
  • Adults aged 18 years or older;
  • Moderate to severe OSA (apnea hypopnea index (AHI) ≥ 15 events/hour) as determined by an overnight polysomnography (PSG) preoperatively;
  • Continunous positive airway pressure failure or intolerance;
  • General good health for surgery;
  • MMA surgery indicated for OSA treatment.
  • For bedpartners of patients:
  • Sharing a bed ⩾2 nights/week with patient.

You may not qualify if:

  • For OSA patients:
  • Other adjunctive procedures indicated at the time of MMA (e.g., multi-piece Le Fort I osteotomy, temporomandibular joint reconstruction);
  • Previous history of orthognathic surgery;
  • Cleft palate and syndromic patients;
  • Refusal to participate.
  • For bedpartners of patients:
  • Refusal to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Oral and Maxillofacial Surgery, Amsterdam UMC

Amsterdam, North Holland, 1105 AZ, Netherlands

Location

MeSH Terms

Conditions

Sleep Apnea SyndromesSleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, doctor

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 20, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

February 28, 2033

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations